Patents by Inventor Erwin Wagner
Erwin Wagner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8105639Abstract: A process of precooking grains which comprises the steps of: a) Charging the grains into a reactor in a controlled manner; b) Applying a first negative pressure to the reactor; c) Heating the grains contained in the reactor; d) Applying a second negative pressure to the reactor; and e) Cooling the grains. Equipment for precooking grains comprises at least one reactor, which is associable with means for applying negative pressure.Type: GrantFiled: July 6, 2009Date of Patent: January 31, 2012Inventor: Werner Erwin Wagner
-
Patent number: 8023165Abstract: Shown is a lens device 16 comprising a displaceable lens 18 and a guide 42, by means of which the lens is guided so as to be capable of being displaced. The lens device 16 comprises a first and a second galvanometric motor 46a, 46b and a first and a second force transmission device 54a, 56a; 54b, 56b, which is coupled to the rotor of the first and second galvanometric motor 46a, 46b, respectively, and which is coupled to the lens 18 at a first and second junction 58a, 58b, respectively. The force transmission device is suitable to convert a rotary motion of the rotor of the first and second galvanometric motor 46a, 46b, respectively, into a displacement motion of the lens 18. The first and the second junction 58a, 58b are thereby spaced apart from one another in a direction at right angles to the displacement direction of the lens 18.Type: GrantFiled: October 31, 2008Date of Patent: September 20, 2011Assignee: Raylase AGInventor: Erwin Wagner
-
Patent number: 7807864Abstract: Disclosed is a transgenic non-human animal with broad or cell type-specific ectopic expression of fra-2 that manifests itself in a fibrotic disease, methods for obtaining such animal and their use. Fra-2 transgenic animals, in particular mice, are useful as model systems for human fibrotic disease, e.g. lung scleroderma and pulmonary fibrosis. Cells obtained from the animal are useful for the analysis of fibrotic disease and for testing compounds useful in the therapy of fibrotic disease.Type: GrantFiled: February 21, 2006Date of Patent: October 5, 2010Assignee: Boehringer Ingelheim International GmbHInventors: Erwin Wagner, Robert Eferl
-
Publication number: 20100003385Abstract: A process of precooking grains which comprises the steps of: a) Charging the grains into a reactor in a controlled manner; b) Applying a first negative pressure to the reactor; c) Heating the grains contained in the reactor; d) Applying a second negative pressure to the reactor; and e) Cooling the grains. Equipment for precooking grains comprises at least one reactor, which is associable with means for applying negative pressure.Type: ApplicationFiled: July 6, 2009Publication date: January 7, 2010Inventor: Werner Erwin Wagner
-
Publication number: 20090242437Abstract: A package for an optical storage medium, comprising: a cover part; a support part having a first part, a second part and a support region, wherein, when an optical storage medium is inserted in the package, the support region abuts at least partly against the optical storage medium; an overlay, wherein the overlay and the second part form a receptacle; a hinge located between the first and second parts, wherein the hinge at least partially runs through the support region; wherein the package is made out of a single piece of paper or cardboard.Type: ApplicationFiled: February 26, 2009Publication date: October 1, 2009Applicant: SONY DADC Austria AGInventors: Dieter DAUM, Guenther Schindlauer, Erwin Wagner, Katherin Feldmaier, Anton Rangetiner
-
Publication number: 20090122377Abstract: Shown is a lens device 16 comprising a displaceable lens 18 and a guide 42, by means of which the lens is guided so as to be capable of being displaced. The lens device 16 comprises a first and a second galvanometric motor 46a, 46b and a first and a second force transmission device 54a, 56a; 54b, 56b, which is coupled to the rotor of the first and second galvanometric motor 46a, 46b, respectively, and which is coupled to the lens 18 at a first and second junction 58a, 58b, respectively. The force transmission device is suitable to convert a rotary motion of the rotor of the first and second galvanometric motor 46a, 46b, respectively, into a displacement motion of the lens 18. The first and the second junction 58a, 58b are thereby spaced apart from one another in a direction at right angles to the displacement direction of the lens 18.Type: ApplicationFiled: October 31, 2008Publication date: May 14, 2009Applicant: RAYLASE AGInventor: Erwin WAGNER
-
Publication number: 20080123704Abstract: Disclosed is a system (10) for regulating the power of a laser beam (12).Type: ApplicationFiled: November 19, 2007Publication date: May 29, 2008Applicant: Raylase AGInventors: Peter Von Jan, Erwin Wagner, Alistair Baillie Gill
-
Patent number: 7247767Abstract: A mouse that is deficient for c-Jun and JunB in the epidermis or in which deletion of c-Jun and JunB can be specifically induced in the epidermis, and methods for obtaining such mice. The mice and keratinocytes derived therefrom are useful as an animal model for psoriasis and psoriatic arthritis.Type: GrantFiled: January 21, 2005Date of Patent: July 24, 2007Assignee: Boehringer Ingelheim International GmbHInventors: Rainer Zenz, Erwin Wagner
-
Publication number: 20060195916Abstract: Disclosed is a transgenic non-human animal with broad or cell type-specific ectopic expression of fra-2 that manifests itself in a fibrotic disease, methods for obtaining such animal and their use. Fra-2 transgenic animals, in particular mice, are useful as model systems for human fibrotic disease, e.g. lung scleroderma and pulmonary fibrosis. Cells obtained from the animal are useful for the analysis of fibrotic disease and for testing compounds useful in the therapy of fibrotic disease.Type: ApplicationFiled: February 21, 2006Publication date: August 31, 2006Applicant: Boehringer Ingelheim International GmbHInventors: Erwin Wagner, Robert Eferl
-
Publication number: 20050268348Abstract: A mouse that is deficient for c-Jun and JunB in the epidermis or in which deletion of c-Jun and JunB can be specifically induced in the epidermis, and methods for obtaining such mice. The mice and keratinocytes derived therefrom are useful as an animal model for psoriasis and psoriatic arthritis.Type: ApplicationFiled: January 21, 2005Publication date: December 1, 2005Applicant: Boehringer Ingelheim International GmbHInventors: Rainer Zenz, Erwin Wagner
-
Patent number: 6834062Abstract: The present invention provides a method and apparatus for controlling laser power, using at least two Brewster windows which are aligned along an axis which is parallel to the direction of the laser beam and which are rotatable around said axis, wherein the first Brewster window is rotated in one direction and the second Brewster window is rotated in the opposite direction. Preferably, both Brewster windows only have to rotate each through +/−45° to control transmission of the laser beam from maximum to minimum.Type: GrantFiled: July 22, 2002Date of Patent: December 21, 2004Assignee: Raylase AGInventors: Stephen Hastings, Peter Dullin, Alistair Gill, Erwin Wagner, Peter von Jan, Wolfgang Hauck
-
Publication number: 20030229912Abstract: A non-human mammal that carries germline mutations in both the p53 and the Fos genes, methods for producing it and cell lines derived therefrom. The p53/Fos double knockout animal, in particular a mouse, is useful as a rhabdomyosarcoma disease model.Type: ApplicationFiled: March 28, 2003Publication date: December 11, 2003Applicant: Boehringer Ingelheim International GmbHInventors: Alexander Fleischmann, Erwin Wagner, Wolfram Jochum, Martin Radolf
-
Publication number: 20030086451Abstract: The present invention provides a method and apparatus for controlling laser power, using at least two Brewster windows which are aligned along an axis which is parallel to the direction of the laser beam and which are rotatable around said axis, wherein the first Brewster window is rotated in one direction and the second Brewster window is rotated in the opposite direction. Preferably, both Brewster windows only have to rotate each through +/−45° to control transmission of the laser beam from maximum to minimum.Type: ApplicationFiled: July 22, 2002Publication date: May 8, 2003Inventors: Stephen Hastings, Peter Dullin, Alistair Gill, Erwin Wagner, Peter Von Jan, Wolfgang Hauck
-
Patent number: 6492575Abstract: Process for producing mammals with defined genetic properties, particularly transgenic mammals. Animals which are derived completely from ES cells are obtained by injecting totipotent cells (embryonic stem cells or embryonic germ cells) genetically manipulated and cultured in vitro into tetraploid blastocysts and implanting the resulting embryo in a foster mother, in a single operation.Type: GrantFiled: December 28, 1999Date of Patent: December 10, 2002Assignee: Boehringer Ingelheim International GmbHInventors: Erwin Wagner, Zhao-Qi Wang
-
Publication number: 20020178457Abstract: Process for producing mammals with defined genetic properties, particularly transgenic mammals. Animals which are derived completely from ES cells are obtained by injecting totipotent cells (embryonic stem cells or embryonic germ cells) genetically manipulated and cultured in vitro into tetraploid blastocysts and implanting the resulting embryo in a foster mother, in a single operation.Type: ApplicationFiled: December 28, 1999Publication date: November 28, 2002Inventors: ERWIN WAGNER, ZHAO-QI WANG
-
Patent number: 5389541Abstract: The invention includes a mouse erythroblastoid cell line whose growth is responsive to levels of erythropoietin present in the cell line's growth medium. Also disclosed are methods of using the mouse erythroblastoid cell line to assay the amount of erythropoietin that is present in a sample.Type: GrantFiled: February 18, 1993Date of Patent: February 14, 1995Assignee: Boehringer Ingelheim International GmbHInventors: Gordon Keller, Harmut Beug, Erwin Wagner
-
Patent number: D609563Type: GrantFiled: October 3, 2008Date of Patent: February 9, 2010Assignee: Sony DADC Austria AGInventors: Dieter Daum, Günther Schindlauer, Erwin Wagner, Kathrin Feldmaier, Anton Rangetiner